Resonance Health Ltd

Company Profile

• Business description

  Resonance Health Ltd is engaged in the development and commercialisation of software-as-a-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used to assess liver iron. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are: SaMD, which derives key revenue; Corporate; TrialsWest; and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America and the Europe, Middle East, and Africa (EMEA) regions.

• Contact

  141 Burswood Road
  Level 1
  Burswood
  PerthWA6100
  AUS

  T: +61 892865300

  https://www.resonancehealth.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Health Information Services

  Fiscal Year End

  Employees

  18